Bringing expertise together as one
BioVendor Group, a leading European innovator in immunodiagnostics and molecular diagnostics, announces a strategic transformation of its organizational structure and a unified presentation under the BioVendor Group brand.
Over the past decade, the group has achieved strong growth - both organically and through acquisitions. This has strengthened its scientific expertise, strong innovation capacity, and a presence in more than 100 markets worldwide.
Driving innovation, strengthening support
The transformation represents a decisive shift in how the group operates. BioVendor Group is evolving from an organization shaped around individual companies and regions to a model structured into three global strategic divisions:
- Immunodiagnostics
- Molecular Diagnostics
- Radio-immunodiagnostics
Each division will be led by a dedicated team, closely cooperating with newly established roles coordinating research, innovation, operations, and customer relations.
The new model strengthens BioVendor Group’s ability to respond flexibly to market needs, accelerate innovation, and remain closely connected with customers and partners. This ensures more effective collaboration, better access to solutions, and support built on mutual trust.
.png)
One brand, one identity
As part of the transformation, BioVendor Group will also introduce a harmonized brand identity. The BioVendor Group brand will become the unifying element across all market appearances and communication channels. For regulatory reasons, established company names such as TestLine, ViennaLab, and DiaSource will remain visible on product packaging as legal manufacturers. Externally, however, the group will present itself under the single identity of BioVendor Group.
Michal Kostka, CEO of BioVendor Group, summed it up: "Our strength lies not in what we have built separately, but in what we will now achieve together. With one face and one voice, BioVendor Group will turn today’s complexity into tomorrow’s clarity, and ambition into real progress for healthcare."
Our vision for better diagnostics
At the core of this transformation lies a renewed vision:
To be the trusted innovator in specialty clinical diagnostics, transforming patient needs into advanced solutions for better care and more effective healthcare systems.
This vision reflects both our ambition and our enduring commitment - to scientific progress, to partnership, and most of all, to improving lives through diagnostics. With this transformation, BioVendor Group is ready to shape the future of diagnostics together with its partners and customers.
About BioVendor Group
BioVendor Group is an international group of biotechnology companies with expertise in immunodiagnostics, molecular diagnostics, and radio-immunodiagnostics. Founded in 1992 in the Czech Republic, the group has grown from a local company into a global innovator with its own research, development, and production of in-vitro diagnostic (IVD) products, supported by an international distribution network. BioVendor Group combines scientific excellence, innovation capacity, and presence in over 100 markets worldwide, making it one of the key players in clinical diagnostics.
